-transparent.png){kind=logo}
The in-vitro activity of Sch 34343, a new penam antibiotic, was tested against 257 Gram-positive isolates from cancer patients, and compared with that of imipenem and amifloxacin. Sch 34343 was extremely active against beta-haemolytic streptococci (Lancefield groups A, B and G) with MIC90s ranging from 0.025 to 0.05 mg/l. It was also active against methicillin-susceptible Staphylococcus aureus and had variable activity against coagulase-negative staphylococci. MIC90 for Listeria monocytogenes was 0.78 mg/l and 84% of enterococcal isolates were inhibited by 6.25 mg/l.
Related Publications
K V Rolston, and
M E Alvarez, and
J F Hoy, and
H C Alderman, and
D H Ho, and
G P Bodey
January 1985,
Antimicrobial agents and chemotherapy,
K V Rolston, and
M E Alvarez, and
J F Hoy, and
H C Alderman, and
D H Ho, and
G P Bodey
October 1987,
The Journal of antimicrobial chemotherapy,
K V Rolston, and
M E Alvarez, and
J F Hoy, and
H C Alderman, and
D H Ho, and
G P Bodey
June 1985,
The Journal of antimicrobial chemotherapy,
K V Rolston, and
M E Alvarez, and
J F Hoy, and
H C Alderman, and
D H Ho, and
G P Bodey
June 1985,
The Journal of antimicrobial chemotherapy,
K V Rolston, and
M E Alvarez, and
J F Hoy, and
H C Alderman, and
D H Ho, and
G P Bodey
June 1985,
The Journal of antimicrobial chemotherapy,
K V Rolston, and
M E Alvarez, and
J F Hoy, and
H C Alderman, and
D H Ho, and
G P Bodey
December 1985,
European journal of clinical microbiology,
K V Rolston, and
M E Alvarez, and
J F Hoy, and
H C Alderman, and
D H Ho, and
G P Bodey
May 1985,
Antimicrobial agents and chemotherapy,
K V Rolston, and
M E Alvarez, and
J F Hoy, and
H C Alderman, and
D H Ho, and
G P Bodey
January 1986,
Infection,
K V Rolston, and
M E Alvarez, and
J F Hoy, and
H C Alderman, and
D H Ho, and
G P Bodey
June 1985,
The Journal of antimicrobial chemotherapy,
K V Rolston, and
M E Alvarez, and
J F Hoy, and
H C Alderman, and
D H Ho, and
G P Bodey
April 2017,
International journal of antimicrobial agents,
